New Drug Therapies for Women with Eclampsia – Impact on Prognosis as Compared to Standard Treatment: A Systematic Review of Randomized Controlled Trials
Abstract
Hypertensive disorders continue to be a major global health concern, impacting millions of pregnant women annually, and have a significant impact on both the mortality and morbidity rates of mothers and neonates. The two major spectrums of disease are pre-eclampsia (PE) and eclampsia. While pre-eclampsia (PE) is characterized by milder symptoms, eclampsia includes hypertensive symptoms plus impaired brain function and seizures or coma. This systematic review aims to explore safer and novel drugs/drug combinations with minimal adverse effects to the mother and fetus, which will cause a rapid decrease in blood pressure, better bioavailability, and prevent life-threatening complications. The PubMed and PubMed Central databases were used to perform a comprehensive literature review from January 2019 to December 2023. The Mesh terms and Boolean operators used were “Pre-eclampsia” OR “Eclampsia” AND “Drug therapy.” There are novel and promising alternatives to mono-therapeutic magnesium sulfate in the treatment of severe PE and eclampsia. These drugs are namely dexmedetomidine, nifedipine in combination with phytosterol, magnesium sulfate, and compound Danshen combinations. The use of these drugs is, however off-label in nature and should be instituted solely on a case-by-case basis at the discretion of the physician. The prospect of a combination therapy being developed from the above drug groups is promising, and these findings should instigate further research to provide the…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Protective effects of tadalafil and N-acetyl cysteine therapy on cisplatin-induced testicular toxicity
- The Use of Generative AI for Scientific Literature Searches for Systematic Reviews: ChatGPT and Microsoft Bing AI Performance Evaluation
- Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
- Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent
- Effectiveness of Low-Intensity Extracorporeal Shock Wave Therapy in Erectile Dysfunction: An Analysis of Sexual Function and Penile Hardness at Erection: An Umbrella Review
- Molecular Docking of Silymarin as a Ligand for Aromatase Enzyme and HIV-1 Reverse Transcriptase Using Molegro Virtual Docker
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.